The facility registration, along with DMF registration and GMP certification provides peace of mind to clients looking to use our iPSCs for clinical and commercial use in the United States, Japan, and other global markets
Srichakra receives European Food Safety approval for its food-grade recycled rPET
The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Moderna's Omicron-specific bivalent booster candidate combines its Omicron-specific booster candidate with its Covid-19 vaccine
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours
Subscribe To Our Newsletter & Stay Updated
